Jacob Biboy
Impact in
- Endocrinology top 1%
- Vibrio bacteria research studies
- Escherichia coli research studies
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Resistance in Bacteria 13
-
- Escherichia coli research studies 9
- Vibrio bacteria research studies 8
- Co-authors
- Waldemar VollmerEefjan BreukinkNina R. SalamaTanneke den BlaauwenZachary PincusLaura K. SycuroJoe GrayAlexander J. F. Egan
- Journals
- PLoS Pathogens (5 papers)mBio (5 papers)eLife (5 papers)Molecular Microbiology (4 papers)Nature Communications (4 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Jacob Biboy
54 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 106
- Endocrinology 444
- Molecular Medicine 412
- Genetics 1.0k
- Parasitology 165
- Microbiology 148
Countries citing papers authored by Jacob Biboy
This map shows the geographic impact of Jacob Biboy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob Biboy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob Biboy more than expected).
Fields of papers citing papers by Jacob Biboy
This network shows the impact of papers produced by Jacob Biboy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob Biboy. The network helps show where Jacob Biboy may publish in the future.
Co-authors
The 25 scholars most cited alongside Jacob Biboy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 4 | |
| 7 | 2024 | 0 | |
| 8 | 2023 | 2 | |
| 9 | 2022 | 6 | |
| 10 | 2022 | 11 | |
| 11 | 2021 | 57 | |
| 12 | 2020 | 28 | |
| 13 | 2020 | 33 | |
| 14 | 2019 | 118 | |
| 15 | 2018 | 19 | |
| 16 | 2018 | 18 | |
| 17 | 2016 | 23 | |
| 18 | 2014 | 64 | |
| 19 | 2013 | 101 | |
| 20 | 2010 | 293 |
About Jacob Biboy
Jacob Biboy is a scholar working on Molecular Medicine, Endocrinology, Parasitology, Genetics and Microbiology, having authored 58 papers that have together received 2.4k indexed citations. Recurring topics across this work include Bacterial Genetics and Biotechnology (23 papers), Antibiotic Resistance in Bacteria (13 papers), Bacterial biofilms and quorum sensing (12 papers), Bacteriophages and microbial interactions (9 papers), Escherichia coli research studies (9 papers), Vibrio bacteria research studies (8 papers), Salmonella and Campylobacter epidemiology (7 papers) and Glycosylation and Glycoproteins Research (6 papers). The work is most often cited by research in Endocrinology (444 citations), Molecular Medicine (412 citations), Genetics (1.0k citations), Parasitology (165 citations) and Microbiology (148 citations). Jacob Biboy has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Waldemar Vollmer, Eefjan Breukink, Nina R. Salama, Tanneke den Blaauwen, Zachary Pincus, Laura K. Sycuro, Joe Gray, Alexander J. F. Egan, Athanasios Typas and Carol A. Gross. Their work appears in journals such as PLoS Pathogens, mBio, eLife, Molecular Microbiology and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.